Zacks.com featured highlights include: Academy Sports and Outdoors, Berry Global, Boise Cascade, Bunge Ltd. and Caleres

For Immediate Release

Chicago, IL – January 7, 2022 – Stocks in this week’s article are Academy Sports and Outdoors ASO, Berry Global BERY, Boise Cascade BCC, Bunge Ltd. BG and Caleres CAL.

– Zacks

5 Broker-Friendly Investment Options to Welcome 2022

With COVID-19 cases rising exponentially in most countries across the globe, including the United States, the economic recovery, witnessed last year, is feared to take a beating this time. Apart from the spike in infection, supply-chain woes pose another challenge to the U.S. economy.

Volatility and uncertainty is likely to be prevalent at least in the near term. Given this scenario, it seems prudent for investors to add stocks to their portfolios that are upgraded by brokers and are also witnessing upward earnings estimate revisions. Stocks like Academy Sports and Outdoors, Berry Global, Boise Cascade, Bunge Ltd. and Caleres fit the bill and should grace the portfolios of investors.

Why Is Broker Advice Necessary?

With a plethora of stocks flooding the market from various industries at any point of time, it is almost impossible for individual investors to come up with a winning portfolio of stocks without proper guidance. Therefore, it is in the best interest of investors to seek advice from “experts in the field.“

Brokers go through minute details of the publicly available financial documents apart from attending company conference calls and other presentations. Since brokers follow the stocks in their coverage in great detail, they revise their earnings estimates after carefully examining the pros and cons of an event for the concerned company. Estimate revisions serve as an important pointer regarding the price of a stock.

To take care of the earnings performance, we designed a screen based on improving analyst recommendations and upward estimate revisions over the last four weeks.

Do Not Ignore the Top Line

However, designing a strategy based solely on the bottom line is unlikely to result in a winning approach. According to many market watchers, a revenue beat is more creditable for a company than a mere earnings outperformance, especially in an environment of revenue weakness due to macroeconomic headwinds. To address top-line concerns, we included the price/sales ratio in our screen, which serves as a strong complementary valuation metric.

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/1848589/5-broker-friendly-investment-options-as-we-welcome-2022

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the „#1 site for screening stocks“ by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They’re virtually unknown to the general public. Yet today’s 220 Zacks Rank #1 „Strong Buys“ were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://www.twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: https://www.zacks.com/

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks „Terms and Conditions of Service“ disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.

Zacks Names „Single Best Pick to Double“

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

As one investor put it, “curing and preventing hundreds of diseases…what should that market be worth?” This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Bunge Limited (BG): Free Stock Analysis Report
 
Berry Global Group, Inc. (BERY): Free Stock Analysis Report
 
Boise Cascade, L.L.C. (BCC): Free Stock Analysis Report
 
Caleres, Inc. (CAL): Free Stock Analysis Report
 
Academy Sports and Outdoors, Inc. (ASO): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Schreibe einen Kommentar

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert.